Assets

Open / close summary

Contribute to de-risk potential phase IIb and phase III studies for sponsors, early in the drug development process.

Contribute to the understanding of the MOA/pharmacology/first signs of efficacy of investigational drugs, on relatively short studies.

Expertise in drugs and medical devices

Direct recruitment and follow up of patients as the Centre of Clinical Investigation (CIC) is located within the ICM, and in neurology/psychiatry units of the Pitié-Salpétrière Hospital which is the biggest European Hospital in neurosciences/psychiatry with 100 000 visits per year of patients.

Deliver highly specific, innovative, informative, tailor-made data with high quality based on industry standards.

Operate with efficiency, agility and reactivity due to a lean organizational structure.